Smith & Nephew SNATS Inc (NYSE:SNN) — Market Cap & Net Worth
Market Cap & Net Worth: Smith & Nephew SNATS Inc (SNN)
Smith & Nephew SNATS Inc (NYSE:SNN) has a market capitalization of $13.21 Billion ($13.21 Billion) as of May 2, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #1785 globally and #658 in its home market, demonstrating a -2.38% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Smith & Nephew SNATS Inc's stock price $31.16 by its total outstanding shares 423903661 (423.90 Million). Analyse Smith & Nephew SNATS Inc cash flow conversion to see how efficiently the company converts income to cash.
Smith & Nephew SNATS Inc Market Cap History: 2015 to 2026
Smith & Nephew SNATS Inc's market capitalization history from 2015 to 2026. Data shows growth from $12.35 Billion to $13.21 Billion (0.60% CAGR).
Smith & Nephew SNATS Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Smith & Nephew SNATS Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.79x
Smith & Nephew SNATS Inc's market cap is 1.79 times its annual revenue
Latest Price to Earnings (P/E) Ratio
25.29x
Smith & Nephew SNATS Inc's market cap is 25.29 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $12.35 Billion | $4.63 Billion | $410.00 Million | 2.67x | 30.13x |
| 2016 | $10.63 Billion | $4.67 Billion | $784.00 Million | 2.28x | 13.56x |
| 2017 | $12.61 Billion | $4.76 Billion | $767.00 Million | 2.65x | 16.43x |
| 2018 | $13.73 Billion | $4.90 Billion | $663.00 Million | 2.80x | 20.70x |
| 2019 | $17.96 Billion | $5.14 Billion | $600.00 Million | 3.50x | 29.93x |
| 2020 | $16.09 Billion | $4.56 Billion | $448.00 Million | 3.53x | 35.92x |
| 2021 | $13.48 Billion | $5.21 Billion | $524.00 Million | 2.59x | 25.73x |
| 2022 | $10.76 Billion | $5.21 Billion | $223.00 Million | 2.06x | 48.25x |
| 2023 | $11.24 Billion | $5.55 Billion | $263.00 Million | 2.03x | 42.73x |
| 2024 | $10.42 Billion | $5.81 Billion | $412.00 Million | 1.79x | 25.29x |
Competitor Companies of SNN by Market Capitalization
Companies near Smith & Nephew SNATS Inc in the global market cap rankings as of May 2, 2026.
Key companies related to Smith & Nephew SNATS Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Smith & Nephew SNATS Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Smith & Nephew SNATS Inc's market cap moved from $12.35 Billion to $ 13.21 Billion, with a yearly change of 0.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $13.21 Billion | -5.03% |
| 2025 | $13.91 Billion | +33.48% |
| 2024 | $10.42 Billion | -7.28% |
| 2023 | $11.24 Billion | +4.44% |
| 2022 | $10.76 Billion | -20.20% |
| 2021 | $13.48 Billion | -16.21% |
| 2020 | $16.09 Billion | -10.40% |
| 2019 | $17.96 Billion | +30.84% |
| 2018 | $13.73 Billion | +8.90% |
| 2017 | $12.61 Billion | +18.57% |
| 2016 | $10.63 Billion | -13.93% |
| 2015 | $12.35 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Smith & Nephew SNATS Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.21 Billion USD |
| MoneyControl | $13.21 Billion USD |
| MarketWatch | $13.21 Billion USD |
| marketcap.company | $13.21 Billion USD |
| Reuters | $13.21 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Smith & Nephew SNATS Inc
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; t… Read more